Micro Labs Limited — Omeprazole Exporter Profile
Indian Pharmaceutical Exporter · #4 for Omeprazole · $17.2M export value · DGFT Verified
Micro Labs Limited is the #4 Indian exporter of Omeprazole with $17.2M in export value and 344 verified shipments. Micro Labs Limited holds a 2.7% market share in Omeprazole exports across 23 countries. The company exports 76 pharmaceutical products worth $463.6M across 21 therapeutic categories.
Micro Labs Limited — Omeprazole Export Profile: Buyers & Destinations
Where Does Micro Labs Limited Export Omeprazole?
| Country | Value | Shipments | Share |
|---|---|---|---|
| KENYA | $1.4M | 87 | 14.3% |
| THAILAND | $1.2M | 51 | 12.7% |
| VIETNAM, DEMOCRATIC REP. OF | $1.2M | 34 | 12.5% |
| ZIMBABWE | $793.5K | 38 | 8.3% |
| NIGERIA | $741.5K | 31 | 7.8% |
| FRANCE | $725.9K | 77 | 7.6% |
| TURKEY | $594.3K | 13 | 6.3% |
| MADAGASCAR | $492.8K | 93 | 5.2% |
| UGANDA | $487.2K | 23 | 5.1% |
| MAURITIUS | $481.0K | 52 | 5.1% |
Micro Labs Limited exports Omeprazole to 30 countries. The largest destination is KENYA accounting for 14.3% of Micro Labs Limited's Omeprazole shipments, followed by THAILAND (12.7%) and VIETNAM, DEMOCRATIC REP. OF (12.5%). These destinations reflect Micro Labs Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Omeprazole from Micro Labs Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| NUTRI-PHARMA USA COMPANY LIMITED | VIETNAM, DEMOCRATIC REP. OF | $963.5K | 30 |
| MICRO NOVA PHARMACEUTICALS IND | NIGERIA | $741.5K | 31 |
| ATLANTA MEDICARE CO. LTD | THAILAND | $663.1K | 27 |
| LABOREX UGANDA LIMITED | KENYA | $566.3K | 38 |
| M/S LABOREX KENYA LIMITED | KENYA | $496.9K | 28 |
| M S LABOREX KENYA LIMITED | KENYA | $463.4K | 21 |
| HAWKARY PHARMACEUTICAL COMPANY | TURKEY | $441.9K | 10 |
| E.P.DIS | FRANCE | $368.3K | 39 |
| DELTA IMPORT-EXPORT MEDICAL CO LTD | VIETNAM, DEMOCRATIC REP. OF | $315.9K | 7 |
| ATLANTA MEDICARE CO LIMITED | THAILAND | $280.7K | 15 |
Micro Labs Limited supplies Omeprazole to 89 buyers globally. The largest buyer is NUTRI-PHARMA USA COMPANY LIMITED (VIETNAM, DEMOCRATIC REP. OF), followed by MICRO NOVA PHARMACEUTICALS IND (NIGERIA) and ATLANTA MEDICARE CO. LTD (THAILAND). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Omeprazole Export Value and How Much Does Micro Labs Limited Contribute?
India exported $248.0M worth of Omeprazole through 15,000 shipments from 975 suppliers to 179 countries, serving 2,858 buyers globally. Micro Labs Limited contributes $17.2M to this total, accounting for 2.7% of India's Omeprazole exports. Micro Labs Limited ships Omeprazole to 30 countries through 89 buyers.
What Is the Average Shipment Value for Micro Labs Limited's Omeprazole Exports?
Micro Labs Limited's average Omeprazole shipment value is $50.0K per consignment, based on 344 shipments totaling $17.2M. The largest destination is KENYA (14.3% of Micro Labs Limited's Omeprazole exports).
How Does Micro Labs Limited Compare to Other Indian Omeprazole Exporters?
Micro Labs Limited ranks #4 among 975 Indian Omeprazole exporters with a 2.7% market share. The top 3 exporters are SUN PHARMACEUTICAL INDUSTRIES LIMITED ($53.6M), CIPLA LIMITED ($44.0M), DR.REDDY'S LABORATORIES LTD ($35.7M). Micro Labs Limited processed 344 shipments to 23 destination countries.
What Omeprazole Formulations Does Micro Labs Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| SOMEXWELL-40 (ESOMEPRAZOLE TABLETS 40MG) | $300.0K | 6 |
| OMICAP-20 (OMEPRAZOLE CAPSULES 20MG) (10 | $255.7K | 6 |
| OMICAP 20 (OMEPRAZOLE CAPSULES 20MG) (50 | $202.2K | 8 |
| OMICAP-20 (OMEPRAZOLE 20MG CAPSULES) (10 | $199.6K | 5 |
| OMICAP 20 ( (Omeprazole 20mg Capsules) ) | $150.9K | 12 |
| OMICAP 20 Omeprazole Capsules 20mg 50X10S QTY- 11738.000 | $100.0K | 2 |
| ESOFAG KIT Amloxicillin 1mg Tablets +Clarithromycin USP 500mg tablets + esomeprazole 20mg tablets 7X1KIT QTY- | $94.6K | 2 |
| OMICAP 20 OMEPRAZOLE CAPSULES 20 mg. 10x | $88.5K | 2 |
| ESOFAG D ESOMEPRAZOLE 40MG ENTERIC-COAT | $81.0K | 4 |
| OMICAP 20 OMEPRAZOLE CAPSULES 20 mg - 10 | $75.8K | 5 |
Micro Labs Limited exports 533 distinct Omeprazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is SOMEXWELL-40 (ESOMEPRAZOLE TABLETS 40MG) with 6 shipments worth $300.0K.
How Does Micro Labs Limited Compare to Nearest Omeprazole Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | DR.REDDY'S LABORATORIES LTD | $35.7M | 714 | 12 | $50.0K |
| 6 | GLENMARK PHARMACEUTICALS LIMITED | $26.7M | 636 | 2 | $41.9K |
| 4 | MICRO LABS LIMITED ★ | $17.2M | 344 | 23 | $50.0K |
| 8 | ZYDUS LIFESCIENCES LIMITED | $13.2M | 313 | 18 | $42.1K |
| 7 | DR REDDYS LABORATORIES LIMITED | $11.7M | 234 | 10 | $50.0K |
Micro Labs Limited ranks #4 among 975 Indian Omeprazole exporters. Average shipment value of $50.0K compared to the market average of $254.4K. The closest competitors by value are DR.REDDY'S LABORATORIES LTD and GLENMARK PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Omeprazole Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 1,900 | 12.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 1,316 | 8.8% |
| DELHI AIR CARGO ACC (INDEL4) | 857 | 5.7% |
| SAHAR AIR | 837 | 5.6% |
| JNPT/ NHAVA SHEVA SEA | 784 | 5.2% |
| HYDERABAD ICD (INSNF6) | 480 | 3.2% |
| Bombay Air | 463 | 3.1% |
| DELHI AIR | 456 | 3.0% |
What Other Gastrointestinal Products Does Micro Labs Limited Export?
Micro Labs Limited also exports these gastrointestinal products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Micro Labs Limited's Omeprazole Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Micro Labs Limited. The Israel-Iran conflict has intensified tensions in the Red Sea, leading to increased shipping costs and potential delays. These disruptions can affect supply chain efficiency and profitability, necessitating strategic adjustments in logistics and distribution channels.
Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply sources, creating an opportunity for Indian exporters to capture a larger market share. Micro Labs can leverage this shift by emphasizing its compliance with U.S. regulatory standards and ensuring a reliable supply chain.
The recent India-European Union Free Trade Agreement, signed in January 2026, is poised to eliminate tariffs on most European pharmaceutical exports to India. While this enhances market access for European manufacturers, it also intensifies competition for Indian exporters. Micro Labs must enhance its value proposition through innovation, cost efficiency, and adherence to EU regulatory standards to maintain its competitive edge. (en.wikipedia.org)
Micro Labs Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for pharmaceutical exporters. Micro Labs Limited has demonstrated a commitment to quality, as evidenced by its recognition as India’s Most Technically and Scientifically Advanced Pharmaceutical Manufacturing Company in 2024. This accolade reflects the company's adherence to stringent manufacturing practices and international guidelines. (einnews.com)
However, the evolving regulatory landscape, including the EU's Falsified Medicines Directive and the U.S. FDA's stringent quality requirements, necessitates continuous investment in compliance infrastructure. Micro Labs must proactively adapt to these changes to ensure uninterrupted market access and maintain its reputation for quality.
About Micro Labs Limited
Micro Labs Limited exports 76 products worth $463.6M. Beyond Omeprazole, top products include Amoxicillin, Potassium, Gabapentin, Losartan, Esomeprazole. View the complete Micro Labs Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Omeprazole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Omeprazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Micro Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 665 individual customs records matching Micro Labs Limited exporting Omeprazole, covering 533 formulations to 30 countries via 89 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 179+ countries, 2,858+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Omeprazole Export Data from Micro Labs Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Micro Labs Limited's Omeprazole exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Micro Labs Limited
Full Company Profile →
76 products · $463.6M total trade · 21 categories
Omeprazole Stats
Company Overview
Top Products by Micro Labs Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Micro Labs Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Omeprazole. For current shipment-level data, contact TransData Nexus.